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Letters to the Editorpostoperatively, can help reduce both
bleeding and ischemic events. Such an
approach requires further studies to
provide a precise and comprehensive
view on the relationship between APT
administrationmanagement and bleed-
ing and ischemic events through
achieved platelet inhibition quantified
by platelet function tests.
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REPLACEMENT TO PREVENT
PATIENT–PROSTHESIS
MISMATCH IN THE ERA OF
VALVE-IN-VALVE
IMPLANTATION
To the Editor:
Patient–prosthesis mismatch (PPM)
is a matter of intense debate in cardiac
surgery. Although there is general sup-
port for the ‘‘bigger is better’’ hypoth-
esis,1 no uniform conclusion can be
drawn about the impact of PPM on
clinical outcome because results areThe Journalinconsistent across studies. More re-
cently, the debate has gained renewed
impetus with the advent of transcath-
eter aortic valve implantation and the
implementation of the valve-in-valve
procedure for degenerated bioprosthe-
ses.2We read with great interest the ar-
ticle by Seiffert and colleagues,3 who
reported their experience with 11 pa-
tients undergoing transcatheter aortic
valve-in-valve implantation. Approxi-
mately half of the study patients had
signs of severe PPM, and the remain-
der had at least moderate PPM, with
the exception of 1 patient, who had
an indexed effective orifice area
greater than 0.85 cm2/m2. In addition,
no significant reduction in transvalvu-
lar gradients was observed after the
procedure in patients with severe
PPM. These results might lead us to
conclude that the procedure was he-
modynamically unsuccessful in 45%
of patients.
The lack of efficacy of the proce-
dure in decreasing aortic valve gradi-
ents is part of a broader controversy
surrounding the optimal treatment
for high-risk patients in the context
of a multidisciplinary management
approach that combines patient needs
and economic resources. As previ-
ously suggested for high-risk patients
by our group,4 we would like to con-
tribute to the debate regarding the
most appropriate valvular procedure
in reoperative surgery by briefly de-
scribing our experience with patients
undergoing reoperative aortic valve
replacement for degenerated biopros-
theses. At our institution, 6 patients
with previous aortic valve replace-
ment underwent implantation with
a Perceval S sutureless valve (Sorin
Group, Saluggia, Italy). Despite their
advanced age at the time of interven-
tion (78.5  4.6 years) and the high
operative risk (logistic EuroSCORE
of 28.5%  20.7%), at 1 year after
implantation all patients are alive
and in good hemodynamic condition
(n¼ 4 in New York Heart Association
class I and n ¼ 2 in New York Heart
Association class II). Notably, theof Thoracic and Cardiovascular Surgesize of the newly implanted valve
was not smaller (22.7 mm vs 23.1
mm), and the indexed effective orifice
area at dischargewas greater than 0.85
cm2/m2 in all patients, with a signifi-
cant reduction in postoperative trans-
valvular gradients (peak gradient
from 75.5  29 mm Hg to 27.5 
3.7 mm Hg; mean gradient from 39.8
 21.6 mm Hg to 14.8  3.3 mm
Hg; P ¼ .031). Although the sample
is limited, these encouraging clinical
and hemodynamic results prompt us
to suggest that sutureless aortic valve
replacement may be considered even
for high-risk patients, in particular
when the diameter of the previously
implanted valve is small, in patients
with small body surface area, or in fe-
male patients.5 At the time of the first
implant, selection of the appropriate
valve size is crucial in the event of
a subsequent valve-in-valve proce-
dure, especially in younger patients.
The valve-in-valve technique is a fea-
sible and promising treatment option,
which is being performed increasingly
in many centers, including our own.
So the real question becomes, is it
worth treating high-risk patients with
this expensive and delicate surgical
procedure if no hemodynamic benefit
will be obtained in approximately
50% of cases?
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ASCENDING-DECENDING
POSTERIOR PERICARDIAL
BYPASS WITH VALVE-SPARING
AORTIC ROOT REPLACEMENT
To the Editor:
We recently read the interesting case
report byAndersonand colleagues1 dis-
cussing the surgical treatment of a pa-
tient with a coarctation of the aorta
andaortic root aneurysm.They success-
fully performed a valve-sparing root
replacement, along with an ascending-
descending posterior pericardial by-
pass. We commend Anderson and
colleagues1 on their excellent result.
We agree that ascending-descending
posterior pericardial bypass should be
considered in adult patients with coarc-
tation of the aorta and concomitant
cardiac pathology requiring surgical
attention through a median sternot-
omy.2,3 The combination of valve-
sparing root replacement and
ascending-descending posterior peri-
cardial bypass was first reported in
2008, when we used this surgical ap-
proach in the successful treatment of
a 20-year-old man with an aortic root
aneurysm and severe coarctation of
the aorta.4 Since that time,wehave per-
formed this operation on 2 more
patients, andwefind it to be a reproduc-
ible solution to a potentially difficult
problem. We are disappointed that
Anderson and colleagues1 failed to
acknowledge our original contribution
4 years ago.
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We read with interest the letter by
Burkhart and Connolly from Mayo
Clinic regarding our recent article de-
scribing ascending-descending aortic
bypass with concomitant valve-
sparing root replacement.1 In 2007,
the Mayo group published the largest
series of aortic bypass operations in
the literature (n ¼ 50) and elegantly
described the general technique of
posterior pericardial aortic bypass
that we used in our case.2 This seminal
2007 article was appropriately refer-
enced in our report. A follow-up
review article from Burkhart and col-
leagues in 2011 reiterated the aortic
bypass technique as well as the out-
comes of the original 50 patients de-
scribed in 2007.3 Of note, neither the
2007 nor 2011 articles described the
performance of any concomitant aor-
tic root operations. Burkhart and Con-
nolly now claim to have first reported
an aortic bypass with valve-sparing
root replacement operation in 2008
and are disappointed that we did not
acknowledge this contribution in our
report. Unfortunately, the case report
from 2008 that describes this opera-
tion fails to make use of appropriate
aortic nomenclature.4 The phrase
‘‘valve-sparing’’ does not appear any-
where within the article, and theardiovascular Surgery c July 2012abstract states only that the ascending
aorta was replaced and makes no ref-
erence to an aortic root operation.
Thus the 2008 case report was not
identified by routine searches of the
indexed medical literature for valve-
sparing operations. The abstract incor-
rectly described ascending aortic
replacement as opposed to aortic root
replacement, and the authors of the
2011 review article from Mayo failed
to update their case series and did not
describe the performance of any addi-
tional concomitant root procedures.
We regret that wewere unable to iden-
tify the 2008 case report and are happy
to acknowledge the Mayo group’s
claim to primacy in performing aortic
bypass with valve-sparing root re-
placement operation at this time.
Nonetheless, we recommend appro-
priate use of aortic nomenclature and
careful review of surgical manuscripts
by a surgeon to avoid confusion in the
future.
Since the time of our previous
report, we have combined ascending-
descending aortic bypass with conven-
tional button Bentall root replacement
and proximal arch (hemiarch) replace-
ment, aswell as supracoronary ascend-
ing aortic and hemiarch replacement.
Both cases were patients with the bi-
cuspid aortic valve syndrome,5 includ-
ing proximal aneurysmal pathology
extending to the level of the proximal
arch.We take this opportunity to claim
primacy for the performance of
concomitant arch replacement with
ascending-descending bypass, be-
cause this is not mentioned in any of
the previous Mayo reports or else-
where in the literature.
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